PIR International is pleased to announce the appointment of Dieter Weinand as Non-Executive Chair at Anaveon.
Anaveon is a global clinical stage biopharmaceutical company that specializes in developing novel treatments for diseases with high unmet needs. The Company was founded in 2017 by scientists and industry experts, who aspire to invent and develop therapeutic treatments that benefit patients and society. The organisation’s mission is to harness the power of the immune system for life-saving treatments.
Dieter is an experienced business leader in the pharmaceutical industry and is the former Chair and CEO of Bayer Pharmaceuticals. During a career stretching back over 30 years he has held various responsibilities in general management, commercial, operational and strategic leadership roles, leading business operations for companies including Bayer, Pfizer, Bristol-Myers Squibb, and Sanofi. He has also led the development, launch, and commercialisation of products in various therapeutic areas, including cardiovascular diseases, oncology, dermatology, immunology, and respiratory and inflammatory diseases. He is currently Chair of the Board of Replimune (REPL), Umoja, and Inspirna, and Executive Chair of the Board of Mnemo Therapeutics as well as serving on the Board of Meliora Therapeutics.
Andreas Katopodis, Chief Executive Officer at Anaveon, said: “We are pleased to welcome Dieter to Anaveon’s Board. He brings a wealth of strategic and operational experience to Anaveon as we look to advance our lead solid tumour programs through clinical studies and expand our pipeline with novel drug candidates.”
Dieter Weinand, Non-Executive Chair at Anaveon, added: “I am very pleased to become Chair of the Board for Anaveon, a company I believe has the potential to make a significant difference in the lives of patients. I look forward to working together with Andreas and the Anaveon team to advance the company through its next stages of growth and to achieve its strategic business and pipeline objectives.”
Click here to read more: Anaveon Appoints Dieter Weinand as Chair of its Board of Directors